ResearchMoz

Hepatitis A Preventive Vaccines - Pipeline Assessment and Market Forecasts to 2019

GlobalData
Published Date » 2012-06-18
No. Of Pages » 65

GlobalData, the industry analysis specialist, has released its new report, Hepatitis A Preventive Vaccines - Pipeline Assessment and Market Forecasts to 2019. The report is an essential source of information and analysis on the global Hepatitis A Preventive Vaccines market. The report identifies the key trends shaping and driving the global Hepatitis A Preventive Vaccines market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Hepatitis A Preventive Vaccines sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

The report provides information on the key drivers and challenges of the Hepatitis A Preventive Vaccines market. Its scope includes - 

  • Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Hepatitis A Preventive Vaccines market revenues data from 2006 to 2011, forecast for eight years to 2019. 
  • Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.
  • Analysis of the current and future competition in the seven key countries Hepatitis A Preventive Vaccines market. 
  • Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications. 
  • Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Hepatitis A Preventive Vaccines market.
  • Analysis of key recent licensing and partnership agreements in Hepatitis A Preventive Vaccines market 

Reasons to buy

The report will enhance your decision making capability. It will allow you to - 

  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline. 
  • Develop business strategies by understanding the trends shaping and driving the global Hepatitis A Preventive Vaccines market. 
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Hepatitis A Preventive Vaccines market in future. 
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. 
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. 
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships. 
  • Whats the next big thing in the global Hepatitis A Preventive Vaccines market landscape? Identify, understand and capitalize.
Table of Contents

1 Table of Contents
1 Table of Contents 3
1.1 List of Tables 5
1.2 List of Figures 6

2 Hepatitis A Introduction 7
2.1 Disease Overview 7
2.2 Epidemiology 8
2.2.1 Historical Vaccination Coverage (2006-2011) 9
2.2.2 Forecast Vaccination Coverage (2011-2019) 9
2.3 Prognosis 10
2.4 Etiology 10
2.5 Pathophysiology 12
2.6 Signs and Symptoms 13
2.7 Diagnosis 14
2.8 Treatment and Management Options 16
2.9 Referral Pathway 18
2.10 GlobalData Pipeline Report Guidance 20

3 Hepatitis A Preventive Vaccines - Market Characterization 21
3.1 Global Hepatitis A Preventive Vaccines Market Size (2006-2011) 21
3.2 Hepatitis A Preventive Vaccines Market Forecast (2011-2019) - Global 22
3.3 Hepatitis A Preventive Vaccines Market Size (2006-2011) - The US 23
3.4 Hepatitis A Preventive Vaccines Market Forecast (2011-2019) - The US 24
3.5 Hepatitis A Preventive Vaccines Market Size (2006-2011) - France 25
3.6 Hepatitis A Preventive Vaccines Market Forecast (2011-2019) - France 26
3.7 Hepatitis A Preventive Vaccines Market Size (2006-2011) - Germany 27
3.8 Hepatitis A Preventive Vaccines Market Forecast (2011-2019) - Germany 28
3.9 Hepatitis A Preventive Vaccines Market Size (2006-2011) - Italy 29
3.10 Hepatitis A Preventive Vaccines Market Forecast (2011-2019) - Italy 30
3.11 Hepatitis A Preventive Vaccines Market Size (2006-2011) - Spain 31
3.12 Hepatitis A Preventive Vaccines Market Forecast (2011-2019) - Spain 32
3.13 Hepatitis A Preventive Vaccines Market Size (2006-2011) - The UK 33
3.14 Hepatitis A Preventive Vaccines Market Forecast (2011-2019) - The UK 34
3.15 Hepatitis A Preventive Vaccines Market Size (2006-2011) - Japan 35
3.16 Hepatitis A Preventive Vaccines Market Forecast (2011-2019) - Japan 36
3.17 Drivers and Barriers for the Hepatitis A Preventive Vaccines Market 37
3.17.1 Drivers for the Hepatitis A Preventive Vaccines Market 37
3.17.2 Barriers for the Hepatitis A Preventive Vaccines Market 37
3.18 Opportunity and Unmet Need Analysis 38
3.19 Key Takeaway 39

4 Hepatitis A Preventive Vaccines - Competitive Assessment 40
4.1 Overview 40
4.2 Strategic Competitor Assessment 40
4.3 Product Profiles for the Major Marketed class of Products in the Hepatitis A Market 41
4.3.1 Havrix 41
4.3.2 Vaqta 42
4.3.3 Twinrix 44
4.3.4 Ambirix 45
4.3.5 Avaxim 46
4.3.6 Epaxal 46
4.4 Key Takeaway 47

5 Hepatitis A Preventive Vaccines - Clinical Trials Mapping 48
5.1 Clinical Trials by Region/Country (The US, EU5 and Japan) 48
5.2 Clinical Trials by Phase 49
5.3 Clinical Trials by Trial Status 50
5.4 Prominent Sponsors 51
5.5 Clinical Trials by Overall Sponsors 52
5.6 Top Companies Participating in Hepatitis A Preventive Vaccines Clinical Trials 53

6 Hepatitis A Preventive Vaccines - Strategic Assessment 54
6.1 Key Events Impacting the Future Market 54
6.2 Hepatitis A Preventive Vaccines: Implications for Future Market Competition 55

7 Hepatitis A Preventive Vaccines - Future Players 56
7.1 Introduction 56
7.2 Company Profiles 56
7.2.1 GlaxoSmithKline 56
7.2.2 Merck & Co 56
7.2.3 Crucell 57

8 KOL Insights 58

9 Hepatitis A Preventive Vaccines - Appendix 59

9.1 Market Definitions 59
9.2 Abbreviations 59
9.3 Bibliography 60
9.4 Methodology 61
9.4.1 Coverage 61
9.4.2 Secondary Research 61
9.4.3 Forecasting 62
9.4.4 Primary Research 64
9.4.5 Expert Panel Validation 65
9.5 Contact Us 65
9.6 Disclaimer 65

List of Tables


Table 1: Comparison between Hepatitis A, B and C 7
Table 2: HAV Endemicity by Region 8
Table 3: Vaccination Coverage (In Percentage) 9
Table 4: Vaccination Coverage (In Percentage) 9
Table 5: History and Physical Examination 14
Table 6: Laboratory and Other Studies for Hepatitis A 15
Table 7: Differential Diagnosis of hepatitis A 15
Table 8: Havrix Dosage and Schedule for Vaccination 16
Table 9: Vaqta Dosage and Schedule for Vaccination 16
Table 10: Twinrix Dosage and Schedule for Vaccination 16
Table 11: UK Guidelines For Hepatitis A Vaccination 17
Table 12: Japanese Hepatitis A Vaccine, Dosage and Schedule 17
Table 13: Hepatitis A Preventive Vaccines Market, Global, Revenue ($m), 2006-2011 21
Table 14: Hepatitis A Preventive Vaccines Market, Global, Forecast ($m), 2011-2019 22
Table 15 Hepatitis A Preventive Vaccines Market, The US, Revenue ($m), 2006-2011 23
Table 16: Hepatitis A Preventive Vaccines, The US, Forecast ($m), 2011-2019 24
Table 17: Hepatitis A Preventive Vaccines Market, France, Revenue ($m), 2006-2011 25
Table 18: Hepatitis A Preventive Vaccines, France, Forecast ($m), 2011-2019 26
Table 19: Hepatitis A Preventive Vaccines Market, Germany, Revenue ($m), 2006-2011 27
Table 20: Hepatitis A Preventive Vaccines Market, Germany, Forecast ($m), 2011-2019 28
Table 21: Hepatitis A Preventive Vaccines Market, Italy, Revenue ($m), 2006-2011 29
Table 22: Hepatitis A Preventive Vaccines Market, Italy, Forecast ($m), 2011-2019 30
Table 23: Hepatitis A Preventive Vaccines Market, Spain, Revenue ($m), 2006-2011 31
Table 24: Hepatitis A Preventive Vaccines, Spain, Forecast ($m), 2011-2019 32
Table 25: Hepatitis A Preventive Vaccines Market, The UK, Revenue ($m), 2006-2011 33
Table 26: Hepatitis A Preventive Vaccines Market, The UK, Forecast ($m), 2011-2019 34
Table 27: Hepatitis A Market, Japan, Revenue ($m), 2006-2011 35
Table 28: Hepatitis A Preventive Vaccines Market, Japan, Forecast ($m), 2011-2019 36
Table 29: Hepatitis A Preventive Vaccines - Clinical Trials by Region/ Country, 2012 48
Table 30: Hepatitis A Preventive Vaccines - Clinical Trials by Phase, 2012 49
Table 31: Hepatitis A Preventive Vaccines - Clinical Trials by Status, 2012 50
Table 32: Hepatitis A Preventive Vaccines - Prominent Sponsors, 2012 51
Table 33: Hepatitis A Preventive Vaccines - Overall Sponsors, 2012 52
Table 34: Hepatitis A Preventive Vaccines - Top Companies Participating in Clinical Trials, 2012 53

List of Figures


Figure 1: Prevalence of Hepatitis A Virus by Region 8
Figure 2: Incidence of Hepatitis A, 1980-2009 10
Figure 3: Pathophysiology of Hepatitis A 12
Figure 4 : Symptoms of Hepatitis A infection 13
Figure 5: Referral Pathway for HAV Vaccination 18
Figure 6: KOL Insights, Hepatitis A Preventive Vaccines in the US, Europe and Japan 19
Figure 7: Hepatitis A Preventive Vaccines Market, Global, Revenue ($m), 2006-2011 21
Figure 8: Hepatitis A Preventive Vaccines Market, Global, Forecast ($m), 2011-2019 22
Figure 9 Hepatitis A Preventive Vaccines, The US, Revenue ($m), 2006-2011 23
Figure 10: Hepatitis A Preventive Vaccines, The US, Forecast ($m), 2011-2019 24
Figure 11: Hepatitis A Preventive Vaccines Market, France, Revenue ($m), 2006-2011 25
Figure 12: Hepatitis A Preventive Vaccines, France, Forecast ($m), 2011-2019 26
Figure 13: Hepatitis A Preventive Vaccines Market, Germany, Revenue ($m), 2006-2011 27
Figure 14: Hepatitis A Preventive Vaccines Market, Germany, Forecast ($m), 2011-2019 28
Figure 15: Hepatitis A Preventive Vaccines Market, Italy, Revenue ($m), 2006-2011 29
Figure 16: Hepatitis A Preventive Vaccines Market, Italy, Forecast ($m), 2011-2019 30
Figure 17: Hepatitis A Preventive Vaccines Market, Spain, Revenue ($m), 2006-2011 31
Figure 18: Hepatitis A Preventive Vaccines Market, Spain, Forecast ($m), 2011-2019 32
Figure 19: Hepatitis A Preventive Vaccines Market, The UK, Revenue ($m), 2006-2011 33
Figure 20 : Hepatitis A Preventive Vaccines Market, The UK, Forecast ($m), 2011-2019 34
Figure 21 : Hepatitis A Preventive Vaccines Market, Japan, Revenue ($m), 2006-2011 35
Figure 22: Hepatitis A Preventive Vaccines Market, Japan, Forecast ($m), 2011-2019 36
Figure 23: Opportunity and Unmet Need in the Hepatitis A Preventive Vaccines Market, 2012 38
Figure 24: KOL Insights, Hepatitis A Preventive Vaccines in the US, Europe and Japan 39
Figure 25: Hepatitis A Preventive Vaccines - Strategic Competitor Assessment, 2012 41
Figure 26: KOL Insights, Hepatitis A Preventive Vaccines in the US, Europe and Japan 47
Figure 27: Hepatitis A Preventive Vaccines - Clinical Trials by Country, 2012 48
Figure 28: Hepatitis A Preventive Vaccines - Clinical Trials by Phase, 2012 49
Figure 29: Hepatitis A Preventive Vaccines - Clinical Trials by Status, 2012 50
Figure 30: Hepatitis A Preventive Vaccines - Prominent Sponsors, 2012 51
Figure 31: Hepatitis A Preventive Vaccines - Overall Sponsors, 2012 52
Figure 32: Hepatitis A Preventive Vaccines - Top Companies Participating in Clinical Trials, 2012 53
Figure 33: Hepatitis A Preventive Vaccines Market - Drivers and Restraints 2012 54
Figure 34: Implications for Future Market Competition in Hepatitis A Preventive Vaccines Market, 2012 55
Figure 35: Hepatitis A Preventive Vaccines - Marketed Products by Company, 2012 56
Figure 36: KOL Insights, Hepatitis A Preventive Vaccines, Major Market 58
Figure 37: GlobalData Market Size Estimation 62
Figure 38 : GlobalData Market Forecasting Model 64

Upcoming Reports:

Green Chemicals And Materials Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018
By - Transparency Market Research
Construction chemicals are the chemicals that are added in specific formulations with the cement or concrete during construction to meet the functional, aesthetic, or design requirements of any infrastructure. Green chemicals are the chemicals that do not contain the components that are harmful to human health or environment. Green chemicals are increasingly preferred in construction industry now-a-days due to their numerous benefits such as strength, increased durability, color, chemical resistance, minimum use of water and cement, ability to withstand climatic changes, and...
HPV Therapeutic Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
Human Papillomaviruses (HPV) are members of papillomaviridae family a group of more than 150 related viruses. These are specifically known as papillomaviruses because of some of its types give rise to a wart or papilloma which are benign growths. Some of them are also associated with certain cancers and known as carcinogenic HPVs. More than 40 types of HPV viruses are easily transferred from one person to another by sexual contact anal and oral. Ithas estimated worldwide prevalence of HPV induced cancer in approximately 12-13%. Cervical cancer is the second largest cause of cancer deaths...
Toluene Market - Global Forecast, Market Share, Trends, Size, Growth and Industry Analysis, 2012 - 2018
By - Transparency Market Research
Toluene is a colorless, water insoluble, volatile, inflammable liquid with odor that resembles paint thinner. It is primarily obtained from petroleum and coal tar. Toluene is commonly used as industrial feedstock and as solvent. It is used in paints, inks, adhesives, disinfectants etc. It is also used as a raw material to manufacture benzene, xylene, TNT, production of pharmaceuticals, dyes and cosmetic nail products.  Toluene is often mixed with gasoline as it improves its octane number. In 2010 almost 85% of the toluene produced globally was used as solvents and...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Microsoft to Complete Nokia Purchase by April 25
Apr 23, 2014  
The Microsoft-Nokia deal that made headlines when it was announced is finally on its way to being completed. This proves that even the most complex deals do culminate with time. This week, Microsoft announced that it would complete the purchase of a major part of Nokia’s hardware assets by Friday. The much discussed deal-though on the brink of completion-has witnessed some adjustments...
Top End Stereo Systems Maker Harman Targets Chinese Auto Market
Apr 22, 2014  
Harman, the U.S.-based audio company that is best known as the provider of automobile stereos for top-end car models such as Mercedes-Benz, BMW and Ferrari, has said that it has signed agreements with two leading Chinese automakers—Chang’An and Geely. The company, that is associated with premium infotainment systems for leading auto makers, said that these new contracts...
Scientists Identify Cure for Dengue
Apr 18, 2014  
In a breakthrough discovery that can change the way dengue is treated, scientists have identified a drug target for the deadly dengue viruses. This discovery may help pave the way for discovery of vaccines that can cure this condition that affects nearly 390 million people throughout the world each year.  Scientists have used a new technique for this discovery to show that a region...
India is Facing a Cancer Crisis
Apr 15, 2014  
India is currently facing a cancer crisis – reports a recent research carried out at the King’s college London, in collaboration with the Tata Memorial Cancer Centre, Mumbai.  The reasons estimated for this crisis comprise of increasing rates of smoking, unequal access to proper treatment and belated diagnosis.  Every year, India witnesses around one...
Microparticle Tags to Check Counterfeit Goods Invented
Apr 14, 2014  
Researchers from the Massachusetts Institute of Technology have invented a new set of microparticles that can easily be read by smartphones and establish the authenticity of currency, electronic items and luxury goods.  This strategy is among those countless measures taken by big brands and companies to label their legitimate products in order to stop illegal copies of the...